Brian N. Bundy

33.6k total citations · 13 hit papers
111 papers, 22.3k citations indexed

About

Brian N. Bundy is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, Brian N. Bundy has authored 111 papers receiving a total of 22.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Obstetrics and Gynecology, 43 papers in Reproductive Medicine and 42 papers in Surgery. Recurrent topics in Brian N. Bundy's work include Endometrial and Cervical Cancer Treatments (47 papers), Ovarian cancer diagnosis and treatment (42 papers) and Cervical Cancer and HPV Research (21 papers). Brian N. Bundy is often cited by papers focused on Endometrial and Cervical Cancer Treatments (47 papers), Ovarian cancer diagnosis and treatment (42 papers) and Cervical Cancer and HPV Research (21 papers). Brian N. Bundy collaborates with scholars based in United States, Canada and United Kingdom. Brian N. Bundy's co-authors include William T. Creasman, Daniel L. Clarke‐Pearson, Paul B. Heller, Howard D. Homesley, Richard J. Zaino, Joan L. Walker, Laila I. Muderspach, James E. Graham, J.T. Thigpen and Frederick B. Stehman and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Brian N. Bundy

111 papers receiving 21.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer

1999 2.0k citations Peter G. Rose, Brian N. Bundy et al. New England Journal of Medicine profile →
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer

2006 1.9k citations Brian N. Bundy, Rebecca N. Baergen et al. New England Journal of Medicine profile →
Intraepithelial CD8⁺tumor-infiltrating lymphocytes and a high CD8⁺/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

2005 1.9k citations Brian N. Bundy, Christine B. Ambrosone et al. profile →
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

2003 1.6k citations Robert F. Ozols, Brian N. Bundy et al. Journal of Clinical Oncology profile →
Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study

1987 1.5k citations William T. Creasman, C. Paul Morrow et al. Cancer profile →
Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma

1999 1.5k citations Henry Keys, Brian N. Bundy et al. New England Journal of Medicine profile →
Randomized Comparison of Fluorouracil Plus Cisplatin Versus Hydroxyurea as an Adjunct to Radiation Therapy in Stage IIB-IVA Carcinoma of the Cervix With Negative Para-Aortic Lymph Nodes: A Gynecologic Oncology Group and Southwest Oncology Group Study

1999 1.2k citations Brian N. Bundy, John H. Malfetano et al. Journal of Clinical Oncology profile →
Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study

1991 1.0k citations Brian N. Bundy, William T. Creasman et al. Gynecologic Oncology profile →
A Randomized Trial of Pelvic Radiation Therapy versus No Further Therapy in Selected Patients with Stage IB Carcinoma of the Cervix after Radical Hysterectomy and Pelvic Lymphadenectomy: A Gynecologic Oncology Group Study

1999 952 citations Alexander Sedlis, Brian N. Bundy et al. Gynecologic Oncology profile →
Phase III Trial of Standard-Dose Intravenous Cisplatin Plus Paclitaxel Versus Moderately High-Dose Carboplatin Followed by Intravenous Paclitaxel and Intraperitoneal Cisplatin in Small-Volume Stage III Ovarian Carcinoma: An Intergroup Study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group

2001 792 citations Brian N. Bundy, Jeffrey M. Fowler et al. Journal of Clinical Oncology profile →
Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study

1990 742 citations Brian N. Bundy, Richard J. Zaino et al. Gynecologic Oncology profile →
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

2011 428 citations Tihamer Orban, Brian N. Bundy et al. The Lancet profile →
The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group study

1992 400 citations W.J. Hoskins, Brian N. Bundy et al. Gynecologic Oncology profile →

Peers

Countries citing papers authored by Brian N. Bundy

Since Specialization

Citations

This map shows the geographic impact of Brian N. Bundy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian N. Bundy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian N. Bundy more than expected).

Fields of papers citing papers by Brian N. Bundy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian N. Bundy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian N. Bundy. The network helps show where Brian N. Bundy may publish in the future.

Co-authorship network of co-authors of Brian N. Bundy

This figure shows the co-authorship network connecting the top 25 collaborators of Brian N. Bundy. A scholar is included among the top collaborators of Brian N. Bundy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian N. Bundy. Brian N. Bundy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A quantitative measure of treatment response in recent‐onset type 1 diabetes 2020 ·Endocrinology Diabetes & Metabolism ·Brian N. Bundy, Jeffrey P. Krischer, (unknown)	10
2	Comparing Beta Cell Preservation Across Clinical Trials in Recent-Onset Type 1 Diabetes 2020 ·Diabetes Technology & Therapeutics ·Laura M. Jacobsen, Brian N. Bundy, (unknown), Desmond Schatz, Mark A. Atkinson, Todd M. Brusko, Clayton E. Mathews, Kevan C. Herold, Stephen E. Gitelman, Jeffrey P. Krischer, Michael J. Haller	39
3	Non-dystrophic myotonia: prospective study of objective and patient reported outcomes 2013 ·Brain ·Jaya Trivedi, Brian N. Bundy, Jeffrey Statland, Mohammad Salajegheh, (unknown), Shannon L. Venance, Yunxia Wang, Doreen Fialho, Emma Matthews, James Cleland, (unknown), Laura Herbelin, Stephen C. Cannon, Anthony A. Amato, Robert C. Griggs, Michael G. Hanna, Richard J. Barohn	76
4	Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial 2011 ·The Lancet ·Diane K. Wherrett, Brian N. Bundy, Dorothy J. Becker, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Carla J. Greenbaum, Kevan C. Herold, Jennifer B. Marks, Roshanak Monzavi, Antoinette Moran, Tihamer Orban, Jerry P. Palmer, Philip Raskin, Henry Rodriguez, Desmond Schatz, Darrell M. Wilson, Jeffrey P. Krischer, Jay S. Skyler	274
5	The presence of the FRA12E/SMRT fragile site in the genome of prostate cancer patients is a predictor of metastatic development 2006 ·Clinical Cancer Research ·Lionel Coignet, Christiane Houde, (unknown), Brian N. Bundy, Mary Nesline, Christine B. Ambrosone, William McLaughlin, Donald L. Trump	1
6	Whole Abdominal Radiotherapy in the Adjuvant Treatment of Patients With Stage III and IV Endometrial Cancer: A Gynecology Oncology Group Study 2005 ·Obstetrical & Gynecological Survey ·Gregory P. Sutton, (unknown), Brian N. Bundy, Tapan Kumar Roy, Howard D. Homesley, John H. Malfetano, Borys Mychalczak, Mary E. King	13
7	Differential expression of survivin-2B and survivin-ΔEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC) 2005 ·Lung Cancer ·Xiang Ling, Jie Yang, (unknown), Nithya Ramnath, Tallal Younis, Brian N. Bundy, Harry K. Slocum, (unknown), Muxiang Zhou, Fengzhi Li	38
8	Tissue Inhibitor of Metalloproteinase 1 Regulates Resistance to Infection 2004 ·Infection and Immunity ·(unknown), Bong-June Yoon, (unknown), M J Preston, Brian N. Bundy, Anna M. van Heeckeren, Zena Werb, Paul D. Soloway	45
9	Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study breakdown → 2003 ·Journal of Clinical Oncology ·Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer, Jeffrey M. Fowler, Daniel L. Clarke‐Pearson, Robert A. Burger, Robert S. Mannel, Koen DeGeest, Ellen M. Hartenbach, Rebecca N. Baergen	1591
10	A Randomized Trial of Pelvic Radiation Therapy Versus No Further Therapy in Selected Patients With Stage IB Carcinoma of the Cervix After Radical Hysterectomy and Pelvic Lymphadenectomy 1999 ·Obstetrical & Gynecological Survey ·Alexander Sedlis, Brian N. Bundy, Marvin Rotman, Samuel S. Lentz, Laila I. Muderspach, Richard J. Zaino	8
11	Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma breakdown → 1999 ·New England Journal of Medicine ·Henry Keys, Brian N. Bundy, Frederick B. Stehman, Laila I. Muderspach, Weldon Chafe, (unknown), Joan L. Walker, Deborah J. Gersell	1486
12	Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer breakdown → 1999 ·New England Journal of Medicine ·Peter G. Rose, Brian N. Bundy, E. Blake Watkins, J.T. Thigpen, (unknown), Mitchell Maiman, Daniel L. Clarke‐Pearson, (unknown)	2049
13	The Prognostic Value of Nuclear Versus Architectural Grading in Endometrial Adenocarcinoma 1994 ·International Journal of Gynecological Pathology ·Richard J. Zaino, Steven G. Silverberg, Henry J. Norris, Brian N. Bundy, C. Paul Morrow, Takashi Okagaki	39
14	Groin dissection versus groin radiation in carcinoma of the vulva: A gynecologic oncology group study 1992 ·International Journal of Radiation OncologyBiologyPhysics ·Frederick B. Stehman, Brian N. Bundy, Gillian Thomas, Mahesh A. Varia, Takashi Okagaki, James A. Roberts, Jeffrey A. Bell, Paul B. Heller	134
15	Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix a gynecologic oncology group study 1992 ·Cancer ·Richard J. Zaino, Samuel Ward, G. Delgado, Brian N. Bundy, H Gore, (unknown), Parvin Ganjei, (unknown)	123
16	Stage III ovarian tumors of low malignant potential treated with cisplatin combination therapy (A Gynecologic Oncology Group Study) 1991 ·Gynecologic Oncology ·Gregory P. Sutton, Brian N. Bundy, George Omura, Edgardo Yordan, Jackson B. Beecham, Thomas A. Bonfiglio	45
17	Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: A Gynecologic Oncology Group study 1990 ·Gynecologic Oncology ·C. Paul Morrow, Brian N. Bundy, Howard D. Homesley, William T. Creasman, Ned B. Hornback, Robert J. Kurman, J.T. Thigpen	114
18	Extraperitoneal versus transperitoneal selective paraaortic lymphadenectomy in the pretreatment surgical staging of advanced cervical carcinoma (A Gynecologic Oncology Group study) 1989 ·Gynecologic Oncology ·Edward B. Weiser, Brian N. Bundy, W.J. Hoskins, Paul B. Heller, (unknown), Philip J. DiSaia, Stephen Curry, John B. Schlaerth, J.T. Thigpen	84
19	Positive groin lymph nodes in superficial squamous cell vulvar cancer 1987 ·American Journal of Obstetrics and Gynecology ·Alexander Sedlis, Howard D. Homesley, Brian N. Bundy, Richard B. Marshall, Edgardo Yordan, Neville F. Hacker, James H. Lee, Charles Whitney	112
20	Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study breakdown → 1987 ·Cancer ·William T. Creasman, C. Paul Morrow, Brian N. Bundy, Howard D. Homesley, James E. Graham, Paul B. Heller	1520

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact